Affymetrix, Johns Hopkins University, Torben Orntoft | GenomeWeb

Affymetrix has received US Patent Number 6,333,155, “Exploiting genomics in the search for new drugs.” The patent covers the use of high-density oligonucleotide probe arrays (read, GeneChips) to monitor changes in mRNA levels in cells treated with drug or therapeutic candidate compounds, in comparison to un-treated cells, in order to determine how the drug affects gene expression and to discover compounds with potentially useful therapeutic affects.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.